Therapeutic medications against diabetes: What we have and what we expect
Publication type: Journal Article
Publication date: 2019-01-01
scimago Q1
wos Q1
SJR: 3.721
CiteScore: 36.0
Impact factor: 17.6
ISSN: 0169409X, 18728294
PubMed ID:
30529309
Pharmaceutical Science
Abstract
Diabetes has become one of the largest global health and economic burdens, with its increased prevalence and high complication ratio. Stable and satisfactory blood glucose control are vital to reduce diabetes-related complications. Therefore, continuous attempts have been made in antidiabetic drugs, treatment routes, and traditional Chinese medicine to achieve better disease control. New antidiabetic drugs and appropriate combinations of these drugs have increased diabetes control significantly. Besides, novel treatment routes including oral antidiabetic peptide delivery, nanocarrier delivery system, implantable drug delivery system are also pivotal for diabetes control, with its greater efficiency, increased bioavailability, decreased toxicity and reduced dosing frequency. Among these new routes, nanotechnology, artificial pancreas and islet cell implantation have shown great potential in diabetes therapy. Traditional Chinese medicine also offer new options for diabetes treatment. Our paper aim to overview these therapeutic methods for diabetes therapy. Proper combinations of these existing anti-diabetic medications and searching for novel routes are both necessary for better diabetes control.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Frontiers in Endocrinology
3 publications, 4.84%
|
|
|
Current Pharmaceutical Design
2 publications, 3.23%
|
|
|
Revista Brasileira de Farmacognosia
2 publications, 3.23%
|
|
|
Bioorganic Chemistry
2 publications, 3.23%
|
|
|
Results in Chemistry
2 publications, 3.23%
|
|
|
European Journal of Medicinal Chemistry
2 publications, 3.23%
|
|
|
Journal of Medicinal Chemistry
2 publications, 3.23%
|
|
|
International Journal of Biological Macromolecules
2 publications, 3.23%
|
|
|
Kidney Diseases
1 publication, 1.61%
|
|
|
International Journal of Molecular Sciences
1 publication, 1.61%
|
|
|
Frontiers in Oncology
1 publication, 1.61%
|
|
|
In Silico Pharmacology
1 publication, 1.61%
|
|
|
Bio-Design and Manufacturing
1 publication, 1.61%
|
|
|
Applied Biological Chemistry
1 publication, 1.61%
|
|
|
Food Science and Biotechnology
1 publication, 1.61%
|
|
|
Acta Pharmacologica Sinica
1 publication, 1.61%
|
|
|
Journal of Biomolecular Structure and Dynamics
1 publication, 1.61%
|
|
|
Chinese Chemical Letters
1 publication, 1.61%
|
|
|
International Journal of Pharmaceutics
1 publication, 1.61%
|
|
|
Saudi Journal of Biological Sciences
1 publication, 1.61%
|
|
|
Food Chemistry Advances
1 publication, 1.61%
|
|
|
Nanotechnology
1 publication, 1.61%
|
|
|
Advanced Drug Delivery Reviews
1 publication, 1.61%
|
|
|
Industrial Crops and Products
1 publication, 1.61%
|
|
|
Microchemical Journal
1 publication, 1.61%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 1.61%
|
|
|
Journal of Food Biochemistry
1 publication, 1.61%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 1.61%
|
|
|
Nanoscale
1 publication, 1.61%
|
|
|
1
2
3
|
Publishers
|
5
10
15
20
|
|
|
Elsevier
20 publications, 32.26%
|
|
|
Springer Nature
11 publications, 17.74%
|
|
|
Frontiers Media S.A.
5 publications, 8.06%
|
|
|
Bentham Science Publishers Ltd.
4 publications, 6.45%
|
|
|
Wiley
3 publications, 4.84%
|
|
|
Taylor & Francis
2 publications, 3.23%
|
|
|
American Chemical Society (ACS)
2 publications, 3.23%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 3.23%
|
|
|
Hindawi Limited
2 publications, 3.23%
|
|
|
S. Karger AG
1 publication, 1.61%
|
|
|
MDPI
1 publication, 1.61%
|
|
|
Korean Society of Food Science and Technology
1 publication, 1.61%
|
|
|
King Saud University
1 publication, 1.61%
|
|
|
IOP Publishing
1 publication, 1.61%
|
|
|
OAE Publishing Inc.
1 publication, 1.61%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.61%
|
|
|
5
10
15
20
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
62
Total citations:
62
Citations from 2024:
19
(30.64%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Hu C., Wei J. Therapeutic medications against diabetes: What we have and what we expect // Advanced Drug Delivery Reviews. 2019. Vol. 139. pp. 3-15.
GOST all authors (up to 50)
Copy
Hu C., Wei J. Therapeutic medications against diabetes: What we have and what we expect // Advanced Drug Delivery Reviews. 2019. Vol. 139. pp. 3-15.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.addr.2018.11.008
UR - https://doi.org/10.1016/j.addr.2018.11.008
TI - Therapeutic medications against diabetes: What we have and what we expect
T2 - Advanced Drug Delivery Reviews
AU - Hu, Cheng
AU - Wei, Jia
PY - 2019
DA - 2019/01/01
PB - Elsevier
SP - 3-15
VL - 139
PMID - 30529309
SN - 0169-409X
SN - 1872-8294
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2019_Hu,
author = {Cheng Hu and Jia Wei},
title = {Therapeutic medications against diabetes: What we have and what we expect},
journal = {Advanced Drug Delivery Reviews},
year = {2019},
volume = {139},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/j.addr.2018.11.008},
pages = {3--15},
doi = {10.1016/j.addr.2018.11.008}
}